Department of Orthopedic surgery, North Khorasan University of Medical Sciences, Bojnurd, Iran.
Department of Modern Sciences and Technologies, Faculty of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran.
Nutr J. 2019 Feb 7;18(1):9. doi: 10.1186/s12937-019-0434-6.
Celiac disease (CD) is known as a reason of metabolic osteopathy. Progression of non-invasive methods such as bone densitometry has shown that an important ratio of CD cases is faced with impaired bone mass and such cases are prone to bone fractures. Variety of low bone mineral density in CD is probably because of ignored confounding factors such as age, menopause, and drug. The aim of our study was to systematically review the osteoporosis and osteopenia incidences among premenopausal females and males with CD.
This systematic review was done based on preferred reporting items for systematic reviews (PRISMA) guidelines. PubMed and Scopus and Cochran databases were searched according to the relevant medical subject headings (MeSH) of CD and bone mineral density until 2018. Prevalence of osteopenia and osteoporosis were used as effect size for meta-analysis. Cochrane Q (p < 0.05) and I index were presented to reveal the heterogeneity.
54 eligible full text reviews were included and nineteen selected for data extraction. Eleven articles didn't have our inclusion criteria and had ignored confounding factors like age and menopause, and we excluded; data extraction was done in eight studies. A total of 563 premenopausal women and men who were from, UK, Brazil, India, Hungary, and Poland were included. The pooled prevalence of osteoporosis was 14.4% [95%CI: 9-20.5%] (Cochrane Q = 7.889, p = 0.96, I = 49.29%), and osteopenia was 39.6% [31.1-48.8%] (Cochrane Q = 14.24, p = 0.07, I = 71.92%), respectively.
Our findings suggest that bone loss is more prevalent in celiac disease and can be associated with increased risk of fracture. However, but results are pooled prevalence and we need more case -control studies with more sample size and consideration of confounding factors.
乳糜泻(CD)是代谢性骨病的一个病因。骨密度等非侵入性方法的进展表明,相当一部分 CD 病例存在骨量减少,此类病例易发生骨折。CD 患者的低骨密度多种多样,可能是因为忽略了年龄、绝经和药物等混杂因素。我们的研究旨在系统评价 CD 患者中绝经前女性和男性的骨质疏松症和骨量减少的发生率。
本系统评价按照系统评价的首选报告项目(PRISMA)指南进行。根据 CD 和骨密度的相关医学主题词(MeSH),在 PubMed 和 Scopus 和 Cochrane 数据库中进行搜索,直到 2018 年。骨质疏松症和骨量减少的患病率被用作荟萃分析的效应量。Cochrane Q(p<0.05)和 I 指数用于显示异质性。
纳入了 54 篇符合条件的全文综述,19 篇被选为数据提取。11 篇文章没有我们的纳入标准,忽略了年龄和绝经等混杂因素,我们排除了这些文章;对 8 项研究进行了数据提取。共纳入了来自英国、巴西、印度、匈牙利和波兰的 563 名绝经前女性和男性。骨质疏松症的总患病率为 14.4%[95%CI:9-20.5%](Cochrane Q=7.889,p=0.96,I=49.29%),骨量减少的患病率为 39.6%[31.1-48.8%](Cochrane Q=14.24,p=0.07,I=71.92%)。
我们的研究结果表明,乳糜泻患者的骨丢失更为常见,可能与骨折风险增加有关。然而,这些结果是汇总的患病率,我们需要更多的病例对照研究,以更大的样本量和考虑混杂因素。